Sunshine Biopharma, Inc. (SBFM) Financials

SBFM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 33.6 million 6.1 million
March 31, 2026 27.9 million 6.4 million
Dec. 31, 2025 30.1 million 7.0 million
Sept. 30, 2025 31.5 million 7.3 million

SBFM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -912847 ?
March 31, 2026 -2.1 million ?
Dec. 31, 2025 -845762 ?
Sept. 30, 2025 -761943 ?

SBFM Net Income

No data available :(

SBFM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 13.7 million - 678338
March 31, 2026 6.9 million - 535614
Dec. 31, 2025 9.1 million - 596785
Sept. 30, 2025 9.3 million - 854761

SBFM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 1.4 million
March 31, 2026 490595
Dec. 31, 2025 490594
Sept. 30, 2025 465168

SBFM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5131 13222 3.9 million 209337
March 31, 2026 5131 31724 3.3 million 308693
Dec. 31, 2025 770244 -530807 8.7 million 308693
Sept. 30, 2025 34143 119298 3.3 million 235217

SBFM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 9.3 million 6.8 million
March 31, 2026 8.1 million 6.0 million
Dec. 31, 2025 8.6 million 5.6 million
Sept. 30, 2025 9.4 million 6.3 million

SBFM

Price: $0.22

52 week price:
0.21
24.30

Earnings Per Share: -12.50 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 1.0 million

Links: